SCHEMBL6652691

SCHEMBL6652691

CN(CCC[C@H](NC(=O)c1ccc(CNCc2ncc[nH]2)cc1)C(=O)NCc1cccc2ccccc12)C1CCCCC1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
MAPK14 Q16539 9/20 0.38
DDR1 Q08345 3/20 0.38
DDR2 Q16832 3/20 0.38
MCHR1 Q99705 4/20 0.38
TP53 P04637 1/20 0.37
MAPT P10636 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NTMT1 Q9BV86 1/20 0.37
GPR88 Q9GZN0 1/20 0.36
ABL1 P00519 1/20 0.36
FGFR3 P22607 1/20 0.36
MAPK11 Q15759 1/20 0.36
MAP3K20 Q9NYL2 1/20 0.36
MAP3K4 Q9Y6R4 1/20 0.36
CCKBR P32239 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6652093 0.89 CXCR4 (0.54) CXCR4MAPK14DDR1DDR2GPR88
SCHEMBL6653505 0.88 CXCR4 (0.54) CXCR4MAPK14DDR1DDR2GPR88
SCHEMBL6018195 0.86 CXCR4 (0.46) CXCR4HDAC3HDAC1HDAC2MCHR1
SCHEMBL6652160 0.85 CXCR4 (0.45) CXCR4HDAC3HDAC1HDAC2MCHR1
SCHEMBL6657781 0.84 CXCR4 (0.43) CXCR4HDAC3HDAC1HDAC2MCHR1
SCHEMBL7023773 0.81 CXCR4 (0.46) CXCR4HDAC3HDAC1HDAC2MCHR1
SCHEMBL6652655 0.80 CXCR4 (0.43) CXCR4HDAC3HDAC1HDAC2MCHR1
SCHEMBL6019474 0.80 HDAC1 (0.45) CXCR4HDAC3HDAC1HDAC2MAPK14
SCHEMBL6018294 0.80 CXCR4 (0.41) CXCR4HDAC3HDAC1HDAC2MCHR1
SCHEMBL6018022 0.80 CXCR4 (0.41) CXCR4HDAC3HDAC1HDAC2MCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040254221-A1 Novel Nitrogenous Compound and use thereof KUREHA CORPORATION (JP) 2004-12-16 US claimed
EP-1431290-A1 NOVEL NITROGENOUS COMPOUND AND USE THEREOF Kureha Chemical Industry Co., Ltd. (JP) 2004-06-23 EP claimed
US-20040254221-A1 Novel Nitrogenous Compound and use thereof KUREHA CORPORATION (JP) 2004-12-16 US disclosed
EP-1431290-A1 NOVEL NITROGENOUS COMPOUND AND USE THEREOF Kureha Chemical Industry Co., Ltd. (JP) 2004-06-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040254221-A1 Novel Nitrogenous Compound and use thereof NGLY1, NOD1, CCR1 CXCR4 88/4885HDAC3 1711/4885HDAC1 393/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.